首页> 外文期刊>Cardiovascular Research >Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation
【24h】

Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation

机译:平滑肌细胞中的Runx2缺失抑制血管骨软骨形成和钙化,但不抑制动脉粥样硬化病变的形成

获取原文
获取原文并翻译 | 示例
           

摘要

Vascular smooth muscle cells (SMCs) are major precursors contributing to osteochondrogenesis and calcification in atherosclerosis. Runt-related transcription factor-2 (Runx2) has been found essential for SMC differentiation to an osteochondrogenic phenotype and subsequent calcification in vitro. A recent study using a conditional targeting allele that produced a truncated Runx2 protein in SMCs of ApoE(-/-) mice showed reduced vascular calcification, likely occurring via reduction of receptor activator of nuclear factor-kappa B ligand (RANKL), macrophage infiltration, and atherosclerotic lesion formation. Using an improved conditional Runx2 knockout mouse model, we have elucidated new roles for SMC-specific Runx2 in arterial intimal calcification (AIC) without effects on atherosclerotic lesion size.
机译:血管平滑肌细胞(SMC)是促成骨软骨形成和动脉粥样硬化钙化的主要前体。已发现矮子相关转录因子2(Runx2)对于SMC分化为骨软骨形成表型和随后的体外钙化至关重要。最近的一项研究使用条件定向等位基因在ApoE(-/-)小鼠的SMC中产生截短的Runx2蛋白,显示血管钙化减少,可能是由于核因子-κB配体(RANKL)受体激活剂的减少,巨噬细胞浸润,和动脉粥样硬化病变的形成。使用改良的条件Runx2基因敲除小鼠模型,我们阐明了SMC特定Runx2在动脉内膜钙化(AIC)中的新作用,而对动脉粥样硬化病变的大小没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号